Comparison of complete vs. culprit-only revascularization in acute myocardial infarction

Ran Chen1, Jingping Lu2

  • 1Department of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

PubMed

Insights

Complete revascularization for acute myocardial infarction with multivessel disease does not significantly reduce major adverse cardiovascular events compared to culprit-only intervention. However, complete revascularization may benefit hypertensive patients long-term.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Percutaneous coronary intervention (PCI) is standard for acute myocardial infarction (AMI) with multivessel disease (MVD).
  • The benefit of PCI in non-infarct-related arteries for AMI with MVD remains debated.
  • This study evaluates clinical outcomes of complete versus culprit-only revascularization before discharge.

Purpose of the Study:

  • To compare the clinical outcomes of complete revascularization (CR) versus culprit-only revascularization (COR) in patients with AMI and MVD.
  • To assess the incidence of major adverse cardiovascular and cerebral events (MACCE) at 1, 6, and 12 months post-PCI.
  • To identify patient subgroups that may benefit from CR.

Main Methods:

  • Retrospective analysis of 173 patients with AMI and MVD undergoing emergent PCI (January 2013 - December 2018).
  • Patients were divided into CR (n=85) and COR (n=88) groups.
  • MACCE, including recurrent angina, MI, in-stent thrombosis, AF, and HF, were compared at follow-up intervals.

Main Results:

  • No significant difference in MACCE between COR and CR groups at 1, 6, or 12 months (36.2% vs. 33.3%, 42.0% vs. 29.7%, 44.9% vs. 36.5%, respectively).
  • The COR group had a significantly higher rate of recurrent angina at 6 months (20.3% vs. 5.4%).
  • Hypertensive patients showed improved outcomes with CR at 6 and 12 months.

Conclusions:

  • Complete revascularization before discharge offers no significant long-term MACCE benefit over culprit-only intervention in AMI patients with MVD.
  • Culprit-only revascularization may be associated with a higher rate of recurrent angina.
  • Hypertension is a potential factor influencing the benefit of complete revascularization.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...